|
ZC3H4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.671500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.864400E-03 |
| Normal-vs-Stage2 |
6.460100E-02 |
| Normal-vs-Stage3 |
4.826600E-01 |
| Normal-vs-Stage4 |
4.699800E-02 |
| Stage1-vs-Stage2 |
9.935400E-01 |
| Stage1-vs-Stage3 |
6.841400E-03 |
| Stage1-vs-Stage4 |
6.566600E-01 |
| Stage2-vs-Stage3 |
7.244000E-02 |
| Stage2-vs-Stage4 |
6.669600E-01 |
| Stage3-vs-Stage4 |
9.381700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.778000E-02 |
| Normal-vs-AfricanAmerican |
9.923700E-02 |
| Normal-vs-Asian |
3.287800E-01 |
| Caucasian-vs-AfricanAmerican |
9.492000E-01 |
| Caucasian-vs-Asian |
9.975200E-01 |
| AfricanAmerican-vs-Asian |
9.835400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.144000E-02 |
| Normal-vs-Female |
5.578000E-01 |
| Male-vs-Female |
1.264840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.945800E-01 |
| Normal-vs-Extreme_Weight |
5.575000E-03 |
| Normal-vs-Obese |
8.977600E-01 |
| Normal-vs-Extreme_Obese |
4.232000E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.269400E-01 |
| Normal_Weight-vs-Obese |
2.607800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.196600E-01 |
| Extreme_Weight-vs-Obese |
1.278410E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.766000E-01 |
| Obese-vs-Extreme_Obese |
1.776790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.998300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.714600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.970800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.963500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.930000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.221800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.464000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.173700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.764000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.505600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.820200E-02 |
| Normal-VS-Type2 PRCC |
8.601900E-03 |
| Normal-VS-KIRP CIMP |
2.286400E-01 |
| Normal-VS-Unclassified PRCC |
8.732000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.820500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.580000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.357600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.237700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.943600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.303600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.817700E-02 |
| Normal-vs-N1 |
2.705400E-01 |
| Normal-vs-N2 |
2.231800E-01 |
| N0-vs-N1 |
5.501800E-03 |
| N0-vs-N2 |
9.819400E-01 |
| N1-vs-N2 |
2.564400E-01 |
|
|
